GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Assurance Acquisition Corp (NAS:HAACU) » Definitions » Debt-to-EBITDA

Health Assurance Acquisition (Health Assurance Acquisition) Debt-to-EBITDA : 0.00 (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Health Assurance Acquisition Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Health Assurance Acquisition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil. Health Assurance Acquisition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil. Health Assurance Acquisition's annualized EBITDA for the quarter that ended in Jun. 2022 was $-1.53 Mil. Health Assurance Acquisition's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Health Assurance Acquisition's Debt-to-EBITDA or its related term are showing as below:

HAACU's Debt-to-EBITDA is not ranked *
in the Diversified Financial Services industry.
Industry Median: 3.965
* Ranked among companies with meaningful Debt-to-EBITDA only.

Health Assurance Acquisition Debt-to-EBITDA Historical Data

The historical data trend for Health Assurance Acquisition's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Assurance Acquisition Debt-to-EBITDA Chart

Health Assurance Acquisition Annual Data
Trend Dec20 Dec21
Debt-to-EBITDA
N/A -

Health Assurance Acquisition Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Debt-to-EBITDA Get a 7-Day Free Trial - - - - -

Competitive Comparison of Health Assurance Acquisition's Debt-to-EBITDA

For the Shell Companies subindustry, Health Assurance Acquisition's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Assurance Acquisition's Debt-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Health Assurance Acquisition's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Health Assurance Acquisition's Debt-to-EBITDA falls into.



Health Assurance Acquisition Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Health Assurance Acquisition's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -6.517
=0.00

Health Assurance Acquisition's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -1.532
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2022) EBITDA data.


Health Assurance Acquisition  (NAS:HAACU) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Health Assurance Acquisition Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Health Assurance Acquisition's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Assurance Acquisition (Health Assurance Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
20 University Road, Cambridge, MA, USA, 02138
Health Assurance Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Executives
Atlas Merchant Capital Llc 10 percent owner 477 MADISON AVENUE, 22ND FLOOR, NEW YORK NY 10022
Mark Joseph Allen officer: Chief Financial Officer 20 UNIVERSITY ROAD, CAMBRIDGE MA 02138
Michelle A Brown officer: Chief Financial Officer C/O HEALTH ASSURANCE ACQUISITION CORP., 20 UNIVERSITY ROAD, CAMBRIDGE MA 02138
Klasko Stephen K. M.d. director 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468
Anita Pramoda director 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Glen Tullman director C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Quentin Clark director 333 BRANNAN STREET, SAN FRANCISCO CA 94107
Hemant Taneja director, officer: Chief Executive Officer C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Jennifer Schneider director C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Evan Sotiriou officer: Chief Operating Officer C/O HEALTHCARE ASSURANCE ACQUISITION, 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138
Health Assurance Economy Foundation 10 percent owner 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138
Haac Sponsor, Llc 10 percent owner C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138